Lithium treatment duration
Lithium treatment duration has been studied in 1 paper since 2016: 1 observational study in people. The newest paper, Apr 12, 2016: “Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients”.
1 paper studies it1 findingUpdated
“After correcting for age, LTL was positively correlated with lithium treatment duration in patients treated for more than two years (n=150, R=0.17, p=0.037).”
- 1 lab in 1 country
- Funder: McGill University
- Humans1
What is Lithium treatment duration linked with?
1Studies link Lithium treatment duration with 1 measure, most often telomere length (1 study).
Telomere length
upin humans1
1 study
Telomere length
upin humans1
Lithium treatment duration is associated with telomere length in humans (R=0.17).
“After correcting for age, LTL was positively correlated with lithium treatment duration in patients treated for more than two years (n=150, R=0.17, p=0.037).”
Humansbipolar disorder; corrected for ageleukocytemore than two yearsn = 150
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Latest
European Neuropsychopharmacology
Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients
Cross-sectional study of 200 peopleTelomere length